Narrative Review of Post-Transplant Immunosuppression and Prophylaxis

This continuing-education narrative review consolidates the pharmacology, dosing, monitoring, and drug-interaction landscape of kidney transplant immunosuppression and infection prophylaxis for renal pharmacy practitioners.

tacrolimuscyclosporinemycophenolateazathioprinebelataceptsirolimuseverolimusbasiliximabanti-thymocyte globulinalemtuzumabcalcineurin inhibitorsmTOR inhibitorskidney transplantimmunosuppressionCMV prophylaxisPJP prophylaxisnarrative reviewdrug interactions Nephrology / Renal Pharmacy

Background Information

Kidney transplant care hinges on effective immunosuppressive and prophylactic medication management.

Managing immunosuppression and its side effects post-kidney transplant is crucial for patient outcomes and graft longevity. The article outlines common immunosuppressants and prophylactic antibiotics used post-transplant, emphasizing side effects and monitoring needs. Information on drug regimens can assist pharmacists in optimizing therapy and ensuring patient safety in kidney transplant recipients. Effective management of immunosuppressants is key to preventing rejection and infection in kidney transplant patients.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Perry A, Kopfman M

Citation: Perry A, Kopfman M Immunosuppressant and Prophylactic Medications in Patients with a Kidney Transplant. Nephrology nursing journal : journal of the American Nephrology Nurses' Association. 2026;53(4):341-348.

Article Links: PubMed

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →